In the present work, we developed robust processes for the preparation of new antitrypanosomal benzofuroxans, E and Z isomers of 5-arylethenylbenzo[1,2-c]1,2,5-oxadiazole N1-oxide 1–6, in multigram ...

Chagas disease (CD) is a neglected infectious condition caused by the protozoan Trypanosoma cruzi (T. cruzi). In 2010, the Pan American Health Organization estimated that approximately 6 to 7 million ...

Chagas disease was first recognized in the modern era by Brazilian doctor Carlos Chagas in 1909. But the disease has been around for 9,000 years. Chagas parasites have been found in the remains of ...

A Key to eight species of Triatoma based on male scutellar morphology is presented. Key words: scutellum - optical microscopy - scanning electron microscopy -Triatominae - Chagas disease Corrêa, in ...

The combination of a calcineurin inhibitor and an antimetabolite remains standard care for graft-versus-host disease (GVHD) prophylaxis in these patients.

Two children from the same family are among seven confirmed cases worldwide with an incurable ultra-rare disease. In November 2022, Mel Dixon, 46, and her husband Charlie, 47, received “the ...

The light-weight device looks for disease biomarkers — in this case, measurable levels of specific proteins — in menstrual blood. It includes a paper test strip that changes color when it's ...

“The main issue with Chagas disease as a public health problem is that most people don’t know they’re infected until symptoms appear and it’s too late to treat them,” UC Assistant Professor Noelia ...

Chagas disease is found across North and South America. Between 6 and 8 million people are believed to be infected, including 300,000 people living in the United States.

Chagas disease (ChD), a neglected tropical disease (NTD) endemic to Latin America, affects 6–7 million people globally, with Brazil accounting for approximately 1.16 million cases (0.6% of its ...

2.2.2 Plant phenology investigation and measurement of morphology, biomass, and stoichiometric indicators 2.2.2.1 Phenology survey For each treatment, the number of days from 1 January 2023 to the ...

Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.